Skip to main content
Caplight Logo









Altheia Science

Altheia Science

Private
MilanHealthcare & Life Scienceshttps://altheiascience.com/

Last Round

Series A

Dec 19, 2018

Total Funding Raised

$19.3M

Company Overview

Altheia Science is a biotechnology company that develops cell and gene therapy strategies to treat autoimmune diseases and cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyhematopoietic stem cellsautoimmune disease treatmentex vivo gene modificationlentiviral engineeringbiotechnologycell therapygene expression modulationcontract development and manufacturing organizationCDMOprecision medicinedrug discoveryclinical trialsbiotech startupcurative medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Altheia Science Comparables

Compare Altheia Science with similar companies based on industry and business-model similarity.

Altheia Science comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Throne Biotechnologies Inc.
73%
Ensoma
72%
Genenta Science
71%

Altheia Science Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 19, 2018

Key People

Founding team and executive leadership

Paolo Rizzardi

Co-Founder, Chairman & CEO

Founding Team

Altheia Science Investors

Notable investors and investment history

Altheia Science investors
InvestorRounds
Fin Posillipo S.p.A.Series A
AurorA-TTSeries A
Advanced Accelerator ApplicationsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2026

    Monthly visitors increased 636% MoM.

Altheia Science Filings

Explore SEC and related filing metadata, where available.

Altheia Science filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Altheia Science's valuation, stock price, and market status.

Is Altheia Science a public or private company?

Altheia Science is a private company.

What is the current stock price of Altheia Science?

Altheia Science is a private company with no public stock price. No recent secondary market data is available.

How much is Altheia Science worth (valuation)?

Valuation information for Altheia Science is not publicly available.

Can I buy Altheia Science stock?

Altheia Science shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Altheia Science's last funding round?

Altheia Science's most recent funding round was Series A on December 19, 2018.

Who are the main investors in Altheia Science?

Key investors in Altheia Science include Fin Posillipo S.p.A., AurorA-TT, Advanced Accelerator Applications.

Will Altheia Science IPO soon?

No public IPO plans have been announced for Altheia Science.

How can I track Altheia Science secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Altheia Science's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMilan
Employee Range3
Year Founded2017
Last FundingDec 19, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?